Bayesian Health Sepsis Monitor Wins Medicare Add-on Payment Approval

Bayesian Health announced on September 2, 2026 that its FDA-cleared sepsis flagging device has been approved for a New Technology Add-on Payment, the Medicare mechanism that temporarily reimburses hospitals for using qualifying new technologies. Beginning October 1, 2026, hospitals using the continuous AI sepsis monitor can receive additional Medicare payment for eligible inpatient cases. The company described the approval as the first reimbursement pathway of its kind for pre-suspicion sepsis…

This article has been indexed from Unite.AI

Read the original article: